In the latest close session, Tilray Brands, Inc. (TLRY) was down 4.34% at $1.66. The stock fell short of the S&P 500, which registered a gain of 0.34% for the day. At the same time, the Dow added 0.09%, and the tech-heavy Nasdaq gained 0.42%.
The company's shares have seen an increase of 38.4% over the last month, surpassing the Medical sector's gain of 1.97% and the S&P 500's gain of 3.54%.
The upcoming earnings release of Tilray Brands, Inc. will be of great interest to investors. The company's earnings report is expected on October 9, 2025. The company's upcoming EPS is projected at -$0.03, signifying a 25.00% increase compared to the same quarter of the previous year. Alongside, our most recent consensus estimate is anticipating revenue of $206.83 million, indicating a 3.39% upward movement from the same quarter last year.
TLRY's full-year Zacks Consensus Estimates are calling for earnings of -$0.11 per share and revenue of $877.28 million. These results would represent year-over-year changes of -1200% and +6.81%, respectively.
Investors should also note any recent changes to analyst estimates for Tilray Brands, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. presently features a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 81, finds itself in the top 33% echelons of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
